NCT03602846|Completed
Diabetes in Pregnancy and Pregnancy Outcomes
Diabetes in Pregnancy, Therapy and Pregnancy Outcomes
Loading search results
Diabetes in Pregnancy, Therapy and Pregnancy Outcomes
Sponsor study identifier
observational
45
0 countries
N/A
Study Start
January 2015
Actual (reported)Primary Completion
December 2015
Actual (reported)Study Completion
June 2016
Actual (reported)To compare the clinical, glycemic profile and therapy as well as pregnancy complications and infant mortality among diabetic mothers in Indonesia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2015
Actual (reported)December 2015
Actual (reported)June 2016
Actual (reported)June 27, 2018
Actual (reported)July 27, 2018
Actual (reported)Infant Mortality
Infant Mortality either due to abortion, intrauterine fetal death or stillbirth as recorded in medical records
Throughout the length of pregnancy, an average of 9 months
Gestational Age at Birth
Infant Gestational at Birth as recorded in medical records
At time of delivery
Infant Body Weight
Infant Body Weight as recorded in medical records
At time of delivery
Infant Body Length
Infant Body Length as recorded in medical records
At time of delivery
Maternal Mortality
Throughout the length of pregnancy, an average of 9 months
Comorbidities
Throughout the length of pregnancy, an average of 9 months
Method of Delivery
At time of delivery
Random Plasma Glucose
Throughout the length of pregnancy, an average of 9 months
Fasting Plasma Glucose
Throughout the length of pregnancy, an average of 9 months
Oral Glucose Tolerance Test
Throughout the length of pregnancy, an average of 9 months
Good outcome is defined as the safe delivery of the newborn.
Poor outcome is defined as the incidence of fetal demise during pregnancy.
Only given medical nutrition therapy.
Prescribed with rapid acting, intermediate acting, mixed or long acting insulin.
Pregnant mothers with gestational and pregestational diabetes diagnosed under the ICD-10 coding of O24.
Anthony P Sunjaya
Tarumanagara University
45 participants (actual enrollment reported by the registry).
First Submitted
June 27, 2018
First Posted
July 27, 2018
Study Start
January 2015
Actual (reported)Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
Infant Head Circumference
Infant Head Circumference as recorded in medical records
At time of delivery
APGAR Score
One and five minute APGAR Scores as recorded in medical records
At time of delivery
Prescribed with all types of oral anti-diabetics.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
December 2015
Actual (reported)Study Completion
June 2016
Actual (reported)Last Updated
July 27, 2018
Record last verified: 2018-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: